This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

Early Bird pricing expires in:

  • 00
  • 00
  • 00
  • 00
Delivered In-Person & Digitally
March 28–30, 2022, Basel, SwitzerlandApril 4–6, 2022, Digital Partnering



We believe Alzheimer's Disease (AD) in humans is originated from the activation, in both neurons and astrocytes, of a transmembrane receptor - the Calcium Sensing Receptor (CaSR) - which starts the vicious cycle of AD negative events. CaSRevolution discovered negative allosteric modulators, or calcilytics, completely counteract CaSR activation, thereby halting AD progression.